FENNEC PHARMACEUTICALS INC (FRX.CA) Forecast, Price Target & Analyst Ratings

Q: What is the average price target for FENNEC PHARMACEUTICALS INC (FRX.CA) stock?

13 analysts have analysed FRX.CA and the average price target is 21.34 CAD. This implies a price increase of 163.4% is expected in the next year compared to the current price of 8.1.

TSX:FRX • CA31447P1009

8.1 CAD

-0.94 (-10.4%)

Last: Apr 10, 2026, 07:00 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FENNEC PHARMACEUTICALS INC (FRX.CA).

Consensus Price Target

Price Target

CA$21.34

+ 163.40% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: May 7, 2026
Period: Q1 / 2026
EPS Estimate: $0.02
Revenue Estimate: 15.512M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

84.62%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

CA$21.34

Upside

+ 163.40%

From current price of CA$8.10 to mean target of CA$21.34, Based on 13 analyst forecasts

Low

CA$18.11

Median

CA$21.80

High

CA$26.07

Price Target Revisions

1 Month

-0.29%

3 Months

9.22%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for FRX.CA. The average price target is 21.34 CAD. This implies a price increase of 163.4% is expected in the next year compared to the current price of 8.1.

The average price target has been revised upward by 9.22% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

84.62%

FRX.CA was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about FRX.CA.

In the previous month the buy percentage consensus was at a similar level.

FRX.CA was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2022-11-23	Cantor Fitzgerald Securities	Upgrade	Overweight
2021-06-03	HC Wainwright & Co.	Maintains	Buy
2021-04-21	Craig-Hallum	Initiate	Buy
2021-04-19	Maxim Group	Initiate	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: May 7, 2026
Period: Q1 / 2026
EPS Estimate: $0.02
Revenue Estimate: 15.512M
Revenue Q2Q: 77.26%
EPS Q2Q: 159.49%
Number of Analysts: 9

Next Earnings Revisions

Revenue (1 Month)

-11.72%

Revenue (3 Months)

-13.01%

EPS (1 Month)

-76.67%

EPS (3 Months)

-80.96%

Next Earnings Summary

FRX.CA is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.02 CAD and the consensus revenue estimate is 15.51M CAD.

The next earnings revenue estimate has been revised downward by 13.01% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Revenue YoY % growth	21.252M 1,280.00%	47.538M 123.69%	44.642M -6.09%	75.749M 69.68%	104M 37.30%	140.79M 35.38%	199.52M 41.71%	217.38M 8.95%	197.72M -9.04%	200.55M 1.43%	151.86M -24.28%
EBITDA YoY % growth	N/A	N/A 216.67%	N/A -69.29%	30.345M 1,283.72%	33.864M 11.60%	52.887M 56.17%	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	-12.771M 43.47%	2.568M 120.11%	-6.282M -344.63%	22.1M 451.80%	35.625M 61.20%	61.455M 72.51%	112.85M 83.63%	120.25M 6.56%	116.7M -2.95%	123.47M 5.80%	81.539M -33.96%
Operating Margin	-60.09%	5.40%	-14.07%	29.18%	34.25%	43.65%	56.56%	55.32%	59.02%	61.57%	53.69%
EPS YoY % growth	-0.61 32.22%	0.00 100.00%	-0.27 -486,388,759,756,013,500.00%	0.43 259.30%	1.09 153.75%	1.53 39.95%	2.83 85.20%	2.85 0.84%	2.26 -20.80%	2.07 -8.58%	0.90 -56.30%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27
EPS Q2Q % growth	0.02 159.49%	0.15 236.00%	0.09 550.48%	0.17 268.30%	0.15 542.95%	0.20 36.36%	0.24 171.71%	0.56 233.33%
Revenue Q2Q % growth	15.512M 77.26%	19.069M 97.57%	19.074M 53.06%	21.687M 57.41%	18.951M 22.17%	19.981M 4.78%	21.379M 12.08%	27.407M 26.38%
EBITDA Q2Q % growth	4.08M 407.69%	15.606M 1,600.00%	7.548M 208.33%	14.28M 218.18%	7.752M 90.00%	9.384M -39.87%	10.812M 43.24%	21.93M 53.57%
EBIT Q2Q % growth	735.624K 191.04%	5.787M 311.82%	3.625M 2,017.99%	7.053M 376.16%	5.61M 662.62%	7.242M 25.14%	8.772M 141.99%	19.89M 182.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

97.10%

EPS Next 5 Year

65.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

45.24%

Revenue Next 5 Year

36.45%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

212.19%

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FENNEC PHARMACEUTICALS INC / FRX.CA Forecast FAQ

What is the average price target for FENNEC PHARMACEUTICALS INC (FRX.CA) stock?

13 analysts have analysed FRX.CA and the average price target is 21.34 CAD. This implies a price increase of 163.4% is expected in the next year compared to the current price of 8.1.

When does FENNEC PHARMACEUTICALS INC (FRX.CA) report earnings?

FENNEC PHARMACEUTICALS INC (FRX.CA) will report earnings on 2026-05-07.

What are the consensus estimates for FENNEC PHARMACEUTICALS INC (FRX.CA) next earnings?

The consensus EPS estimate for the next earnings of FENNEC PHARMACEUTICALS INC (FRX.CA) is 0.02 CAD and the consensus revenue estimate is 15.51M CAD.

What is the expected long term growth rate for FRX stock?

The expected long term growth rate for FENNEC PHARMACEUTICALS INC (FRX.CA) is 45.24%.

Analyst forecast overview

Forecast Snapshot